Full Text View
Tabular View
No Study Results Posted
Related Studies
A Pilot Study of Neurocysticercosis Treatment
This study has been completed.
Study NCT00283699   Information provided by National Institute of Neurological Disorders and Stroke (NINDS)

First Received on January 26, 2006.   Last Updated on February 5, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Neurocysticercosis
Additional conditions recognized in this trial
Cysticercosis
Taeniasis
More general conditions related to this trial
Central Nervous System Diseases
Central Nervous System Helminthiasis
Central Nervous System Infections
Central Nervous System Parasitic Infections
Cestode Infections
Helminthiasis
Nervous System Diseases
Parasitic Diseases
Interventions listed in this trial
albendazole
placebo
More general drug interventions related to this trial
Anthelmintics
Anti-Infective Agents
Anticestodal Agents
Antimitotic Agents
Antineoplastic Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Columbia University
National Institute of Neurological Disorders and Stroke (NINDS)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services